Annual EBITDA
$4.31 B
+$5.49 B+465.89%
31 March 2024
Summary:
Roivant Sciences annual earnings before interest, taxes, depreciation & amortization is currently $4.31 billion, with the most recent change of +$5.49 billion (+465.89%) on 31 March 2024. During the last 3 years, it has risen by +$5.21 billion (+581.19%). ROIV annual EBITDA is now at all-time high.ROIV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$336.87 M
-$425.30 M-480.96%
30 September 2024
Summary:
Roivant Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$336.87 million, with the most recent change of -$425.30 million (-480.96%) on 30 September 2024. Over the past year, it has dropped by -$142.52 million (-73.33%). ROIV quarterly EBITDA is now -106.59% below its all-time high of $5.11 billion, reached on 31 December 2023.ROIV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$4.69 B
-$142.52 M-2.95%
30 September 2024
Summary:
Roivant Sciences TTM earnings before interest, taxes, depreciation & amortization is currently $4.69 billion, with the most recent change of -$142.52 million (-2.95%) on 30 September 2024. Over the past year, it has increased by +$5.72 billion (+551.04%). ROIV TTM EBITDA is now -2.95% below its all-time high of $4.83 billion, reached on 30 June 2024.ROIV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ROIV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +465.9% | -73.3% | +551.0% |
| 3 y3 years | +581.2% | -50.6% | +594.8% |
| 5 y5 years | - | - | - |
ROIV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
| 5 y | 5 years | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
| alltime | all time | at high | +465.9% | -106.6% | +8.6% | -3.0% | +460.0% |
Roivant Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$336.87 M(-481.0%) | $4.69 B(-3.0%) |
| June 2024 | - | $88.43 M(-149.4%) | $4.83 B(+9.0%) |
| Mar 2024 | $4.31 B(-465.9%) | -$179.05 M(-103.5%) | $4.43 B(-0.3%) |
| Dec 2023 | - | $5.11 B(-2730.9%) | $4.44 B(-527.7%) |
| Sept 2023 | - | -$194.35 M(-37.6%) | -$1.04 B(-9.3%) |
| June 2023 | - | -$311.34 M(+89.0%) | -$1.14 B(-2.8%) |
| Mar 2023 | -$1.18 B | -$164.69 M(-55.3%) | -$1.18 B(-9.5%) |
| Dec 2022 | - | -$368.48 M(+22.7%) | -$1.30 B(+5.3%) |
| Sept 2022 | - | -$300.35 M(-12.8%) | -$1.24 B(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$344.50 M(+19.5%) | -$1.16 B(+26.9%) |
| Mar 2022 | -$910.77 M(+1.7%) | -$288.30 M(-4.9%) | -$913.63 M(-7.8%) |
| Dec 2021 | - | -$303.18 M(+35.5%) | -$991.01 M(+4.7%) |
| Sept 2021 | - | -$223.69 M(+127.2%) | -$946.90 M(+7.6%) |
| June 2021 | - | -$98.47 M(-73.1%) | -$879.76 M(-1.8%) |
| Mar 2021 | -$895.74 M | -$365.67 M(+41.1%) | -$895.74 M(+69.0%) |
| Dec 2020 | - | -$259.07 M(+65.5%) | -$530.06 M(+95.6%) |
| Sept 2020 | - | -$156.54 M(+36.8%) | -$270.99 M(+136.8%) |
| June 2020 | - | -$114.45 M | -$114.45 M |
FAQ
- What is Roivant Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Roivant Sciences?
- What is Roivant Sciences annual EBITDA year-on-year change?
- What is Roivant Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Roivant Sciences?
- What is Roivant Sciences quarterly EBITDA year-on-year change?
- What is Roivant Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Roivant Sciences?
- What is Roivant Sciences TTM EBITDA year-on-year change?
What is Roivant Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ROIV is $4.31 B
What is the all time high annual EBITDA for Roivant Sciences?
Roivant Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is $4.31 B
What is Roivant Sciences annual EBITDA year-on-year change?
Over the past year, ROIV annual earnings before interest, taxes, depreciation & amortization has changed by +$5.49 B (+465.89%)
What is Roivant Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ROIV is -$336.87 M
What is the all time high quarterly EBITDA for Roivant Sciences?
Roivant Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.11 B
What is Roivant Sciences quarterly EBITDA year-on-year change?
Over the past year, ROIV quarterly earnings before interest, taxes, depreciation & amortization has changed by -$142.52 M (-73.33%)
What is Roivant Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ROIV is $4.69 B
What is the all time high TTM EBITDA for Roivant Sciences?
Roivant Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $4.83 B
What is Roivant Sciences TTM EBITDA year-on-year change?
Over the past year, ROIV TTM earnings before interest, taxes, depreciation & amortization has changed by +$5.72 B (+551.04%)